foxo4-dri senolytic The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI: Human Trial Status, Cancer
FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 DRI FOXO4 p53 Interaction Blocker MedChemExpress FOXO4 DRI UK Senolytic Peptide Research Peptides Lab UK FOXO4 DRI Dosing: 1mg Senolytic Protocol (2026) Molecular targets of senolytic drugs. Download Scientific Diagram
Pay in 4 interest-free payments of $6.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



